OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Different Disease Pathways to Idiopathic Parkinson’s Disease: Three Genetically-Defined Subgroups with Different Treatment Responses in Phase III Disease-Modifying Trials and Distinct Clinical Trajectories
Antony is a cell & molecular biologist and geneticist with strong research interests into the causative mechanism(s) of Parkinson’s Disease, and therapeutic approaches to successfully treat PD patients, especially with respect to slowing disease progression in idiopathic patients.
Recently in his role as the Research Director of the Australian Parkinson’s Mission, Antony and his collaborators have made substantial progress in identifying three genetically-defined subgroups of idiopathic patients whose analysis supports three differing disease mechanisms.
Date:
23 June 2025, 12:00
Venue:
Dorothy Crowfoot Hodgkin Building, off South Parks Road OX1 3QU
Venue Details:
This seminar will be held in the Dorothy Crowfoot Hodgkin Building, Ground Floor Seminar Room (20-138). Email: opdc.administrator@dpag.ox.ac.uk for more details.
Speaker:
Associate Professor Antony Cooper (Garvan Institute of Medical Research, Australia)
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Lorraine Dyson (University of Oxford)
Host:
Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of:
OPDC Seminar Series (DPAG)
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Lorraine Dyson
